Bluebird Bio
A company developing gene therapies for the treatment of genetic diseases and cancer.
6
Funding Rounds
$262.4m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ph****** Le****** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Bluebird Bio has raised a total of $125m in funding over 6 rounds.
Key Insights:
- bluebird bio Series D round: $60m
- bluebird bio funding round, April 2011: $30m
- bluebird bio Series B round: $35m
- bluebird bio, Inc. funding round, July 2012: $60m
- Genetix Pharmaceuticals Inc funding round, March 2010: $47.41m
- bluebird bio, Inc. funding round, April 2011: $30m
bluebird bio Series D round
$60m
bluebird bio funding round, April 2011
$30m
bluebird bio Series B round
$35m
bluebird bio, Inc. funding round, July 2012
$60m
Genetix Pharmaceuticals Inc funding round, March 2010
$47.41m
bluebird bio, Inc. funding round, April 2011
$30m
Industries
Bluebird Bio is active in the following industries:
- Regenerative medicine
- Gene therapy
- CAR T-Cell therapy
- Biomedical engineering
- T cell
- Epigenetics
- Biology
- Biotechnology
- Healthcare
- Genomics
- Engineering
- Tissue engineering
- Immunotherapy
- Cell therapy
- Genome editing
- Drug discovery
- Genetic engineering
- Technology
- RNA-based and RNA-targeted therapeutics
- Rare disease